IL129237A0 - Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms - Google Patents

Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms

Info

Publication number: IL129237A0
Authority: IL; Israel
Prior art keywords: colonisation; mupirocin; nasopharynx; medicament; manufacture
Prior art date: 1996-10-01

Application number

IL12923797A

Other languages

English (en)

Original Assignee

Smithkline Beecham Corp

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-01

Filing date

1997-09-29

Publication date

2000-02-17

1997-08-09 Priority claimed from GBGB9716805.8A external-priority patent/GB9716805D0/en

1997-09-11 Priority claimed from GBGB9719203.3A external-priority patent/GB9719203D0/en

1997-09-29 Application filed by Smithkline Beecham Corp, Smithkline Beecham Plc filed Critical Smithkline Beecham Corp

2000-02-17 Publication of IL129237A0 publication Critical patent/IL129237A0/xx

Links

MINDHVHHQZYEEK-UHFFFAOYSA-N (E)-(2S,3R,4R,5S)-5-[(2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl]tetrahydro-3,4-dihydroxy-(beta)-methyl-2H-pyran-2-crotonic acid ester with 9-hydroxynonanoic acid Natural products CC(O)C(C)C1OC1CC1C(O)C(O)C(CC(C)=CC(=O)OCCCCCCCCC(O)=O)OC1 MINDHVHHQZYEEK-UHFFFAOYSA-N 0.000 title 1
208000035143 Bacterial infection Diseases 0.000 title 1
208000022362 bacterial infectious disease Diseases 0.000 title 1
239000003814 drug Substances 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
229960003128 mupirocin Drugs 0.000 title 1
229930187697 mupirocin Natural products 0.000 title 1
DDHVILIIHBIMQU-YJGQQKNPSA-L mupirocin calcium hydrate Chemical compound O.O.[Ca+2].C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1.C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1 DDHVILIIHBIMQU-YJGQQKNPSA-L 0.000 title 1
210000001989 nasopharynx Anatomy 0.000 title 1
244000052769 pathogen Species 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Otolaryngology (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IL12923797A 1996-10-01 1997-09-29 Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms IL129237A0 (en)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
US2722396P	1996-10-01	1996-10-01
US2722496P	1996-10-01	1996-10-01
US2722296P	1996-10-01	1996-10-01
GBGB9716805.8A GB9716805D0 (en)	1997-08-09	1997-08-09	Novel composition and use
GBGB9719203.3A GB9719203D0 (en)	1997-09-11	1997-09-11	Novel composition and use
PCT/GB1997/002664 WO1998014189A1 (en)	1996-10-01	1997-09-29	Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms

Publications (1)

Publication Number	Publication Date
IL129237A0 true IL129237A0 (en)	2000-02-17

Family

ID=27517419

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL12923797A IL129237A0 (en)	1996-10-01	1997-09-29	Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms

Country Status (17)

Country	Link
US (1)	US6001870A (xx)
EP (1)	EP0939631A1 (xx)
JP (1)	JP2001504091A (xx)
KR (1)	KR20000048812A (xx)
CN (1)	CN1239427A (xx)
AR (1)	AR010995A1 (xx)
AU (1)	AU724070B2 (xx)
BR (1)	BR9711843A (xx)
CA (1)	CA2267248A1 (xx)
CZ (1)	CZ112499A3 (xx)
HU (1)	HUP9904308A3 (xx)
IL (1)	IL129237A0 (xx)
NO (1)	NO991548L (xx)
NZ (1)	NZ334913A (xx)
PL (1)	PL332642A1 (xx)
TR (1)	TR199900733T2 (xx)
WO (1)	WO1998014189A1 (xx)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CO4910145A1 (es) *	1996-10-01	2000-04-24	Smithkline Beecham Corp	Uso
NZ334913A (en) *	1996-10-01	2001-03-30	Smithkline Beecham Plc	Use of mupirocin (pseudomonic acid) for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms effective as a sprayable topical agent
EP1001747A1 (en) *	1997-08-09	2000-05-24	Smithkline Beecham Plc	Compositions for nasal administration
UY25225A1 (es)	1997-10-29	2000-12-29	Smithkline Beecham Plc	Derivados de pleuromutilina utiles como agentes antimicrobianos
GB9808470D0 (en)	1998-04-22	1998-06-17	Smithkline Beecham Plc	Novel process and apparatus
GB9902138D0 (en)	1999-02-02	1999-03-24	Smithkline Beecham	Container
HRP20010576A2 (en) *	1999-02-03	2002-08-31	Biogal Gyogyszergyar	Process for the preparation of pseudomonic acid a antibiotic by microbiological method
EP1185246A1 (de) *	1999-06-02	2002-03-13	Klöcker, Norbert, Dr.med.	Pharmazeutische zusammmensetzung zur nasalen anwendung von wasserunlöslichen und/oder schwer wasserlöslischen wirkstoffen
US6676930B2 (en) *	1999-11-28	2004-01-13	Scientific Development And Research, Inc.	Composition and method for treatment of otitis media
US6156294A (en) *	1999-11-28	2000-12-05	Scientific Development And Research, Inc.	Composition and method for treatment of otitis media
HUP0500797A2 (en) *	2001-06-21	2007-06-28	Biogal Gyogyszergyar	Metabolic controlled fermentation process for pseudomonic acid production
EP1455769A4 (en)	2001-12-28	2004-09-22	Biogal Gyogyszergyar	METHOD FOR PRODUCING CRYSTALLINE AND AMORPHIC MUPIROCIN CALCIUM
US20050058673A1 (en) *	2003-09-09	2005-03-17	3M Innovative Properties Company	Antimicrobial compositions and methods
DK1641438T3 (da) *	2004-06-01	2010-06-07	Teva Gyogyszergyar Zartkoeruen	Fremgangsmåde til fremstilling af den amorfe form af et lægemiddel
CN101175474B (zh)	2005-03-10	2011-09-07	3M创新有限公司	降低微生物污染的方法
WO2006099325A2 (en) *	2005-03-10	2006-09-21	3M Innovative Properties Company	Methods of treating ear infections
CA2599667C (en)	2005-03-10	2014-12-16	3M Innovative Properties Company	Antimicrobial compositions comprising esters of hydroxy carboxylic acids
GB2437488A (en) *	2006-04-25	2007-10-31	Optinose As	Pharmaceutical oily formulation for nasal or buccal administration
US7993675B2 (en)	2006-05-10	2011-08-09	Medtronic Xomed, Inc.	Solvating system and sealant for medical use in the sinuses and nasal passages
US20070264296A1 (en)	2006-05-10	2007-11-15	Myntti Matthew F	Biofilm extracellular polysachharide solvating system
US7976873B2 (en)	2006-05-10	2011-07-12	Medtronic Xomed, Inc.	Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
US7959943B2 (en)	2006-05-10	2011-06-14	Medtronics Xomed, Inc.	Solvating system and sealant for medical use in the middle or inner ear
US8088095B2 (en)	2007-02-08	2012-01-03	Medtronic Xomed, Inc.	Polymeric sealant for medical use
ES2759373T3 (es)	2008-06-12	2020-05-08	Medtronic Xomed Inc	Producto para el tratamiento de heridas crónicas con un sistema extracelular de solvatación de sustancias poliméricas
US20100021563A1 (en) *	2008-07-24	2010-01-28	Paul Levesque	Compositions comprising coconut oil and methods of use thereof
US20100086576A1 (en)	2008-10-06	2010-04-08	Myntti Matthew F	Antimicrobial composition and methods of making and using same
JP6463629B2 (ja)	2011-05-10	2019-02-06	ネクストサイエンスアイピーホールディングスピーティワイエルティーディ	抗菌性固体およびその製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ200918A (en) *	1981-07-02	1985-07-31	Gist Brocades Nv	Stable fatty oil-in-water emulsion cream for topical application
CA1196284A (en) *	1982-05-28	1985-11-05	Joshua Oduro-Yeboah	Pharmaceutical formulations
SE8206744D0 (sv) *	1982-11-26	1982-11-26	Fluidcarbon International Ab	Preparat for kontrollerad avgivning av substanser
GB8415579D0 (en) *	1984-06-19	1984-07-25	Beecham Group Plc	Compounds
GB8530796D0 (en) *	1985-12-13	1986-01-22	Beecham Group Plc	Pharmaceutical composition
IE59628B1 (en) *	1986-06-26	1994-03-09	Beecham Group Plc	Treatment of fungal infections
US5594026A (en) *	1990-12-11	1997-01-14	Smithkline Beecham Group P.L.C.	Polymorphs of crystalline mupirocin
WO1995010999A1 (en) *	1993-10-22	1995-04-27	Smithkline Beecham Corporation	Novel composition
NZ334913A (en) *	1996-10-01	2001-03-30	Smithkline Beecham Plc	Use of mupirocin (pseudomonic acid) for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms effective as a sprayable topical agent

1997
- 1997-09-29 NZ NZ334913A patent/NZ334913A/en unknown
- 1997-09-29 CZ CZ991124A patent/CZ112499A3/cs unknown
- 1997-09-29 TR TR1999/00733T patent/TR199900733T2/xx unknown
- 1997-09-29 CA CA002267248A patent/CA2267248A1/en not_active Abandoned
- 1997-09-29 EP EP97943966A patent/EP0939631A1/en not_active Withdrawn
- 1997-09-29 CN CN97180242A patent/CN1239427A/zh active Pending
- 1997-09-29 WO PCT/GB1997/002664 patent/WO1998014189A1/en not_active Application Discontinuation
- 1997-09-29 HU HU9904308A patent/HUP9904308A3/hu unknown
- 1997-09-29 IL IL12923797A patent/IL129237A0/xx unknown
- 1997-09-29 PL PL97332642A patent/PL332642A1/xx unknown
- 1997-09-29 JP JP51631398A patent/JP2001504091A/ja active Pending
- 1997-09-29 KR KR1019990702807A patent/KR20000048812A/ko not_active Withdrawn
- 1997-09-29 BR BR9711843-5A patent/BR9711843A/pt not_active IP Right Cessation
- 1997-09-29 AU AU45623/97A patent/AU724070B2/en not_active Ceased
- 1997-09-30 US US08/940,730 patent/US6001870A/en not_active Expired - Fee Related
- 1997-09-30 AR ARP970104497A patent/AR010995A1/es unknown
1999
- 1999-03-30 NO NO991548A patent/NO991548L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
NZ334913A (en)	2001-03-30
AU4562397A (en)	1998-04-24
HUP9904308A3 (en)	2002-06-28
NO991548L (no)	1999-03-31
AR010995A1 (es)	2000-08-02
AU724070B2 (en)	2000-09-14
US6001870A (en)	1999-12-14
EP0939631A1 (en)	1999-09-08
CZ112499A3 (cs)	1999-08-11
BR9711843A (pt)	2001-07-31
CN1239427A (zh)	1999-12-22
WO1998014189A1 (en)	1998-04-09
HUP9904308A2 (hu)	2001-04-28
PL332642A1 (en)	1999-09-27
KR20000048812A (ko)	2000-07-25
CA2267248A1 (en)	1998-04-09
JP2001504091A (ja)	2001-03-27
TR199900733T2 (xx)	1999-07-21
NO991548D0 (no)	1999-03-30

Publication	Publication Date	Title
IL129237A0 (en)	2000-02-17	Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms
NZ506058A (en)	2003-04-29	Antibacterial 9-substituted tetracyclines, and pharmaceuticals and uses thereof
WO2001045679A3 (de)	2002-07-18	Verwendung von chemotherapeutika zur topischen behandlung
GB0125222D0 (en)	2001-12-12	Composition for the treatment of microbial infections
KR0145958B1 (en)	1998-08-17	Antibacterial agents
IL239913B (en)	2019-01-31	The use of delvavancin in a pharmaceutical carrier is accepted in the production of a drug for the treatment of bacterial infections
PT102450A (pt)	2001-02-01	Formulacao farmaceutica de libertacao modificada compreendendo amoxicilina e clavulanato de potassio e utilizacao destes compostos no fabrico de um medicamento para o tratamento de infeccoes bacterianas
HUP0201117A3 (en)	2004-01-28	Attenuated microorganisms for the treatment of infection
AU2000255628A1 (en)	2001-10-08	Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
WO1997018790A3 (en)	1997-07-31	Therapeutic and diagnostic agents for the treatment of microbial infections
CA2267309A1 (en)	1998-04-02	Use of 1-hydroxy-2-pyridones for the treatment of skin infections
FR2782093B1 (fr)	2002-02-08	Procede de preparation de cultures de bacteries lactiques
PL371524A1 (en)	2005-06-27	Combination therapy for the treatment of bacterial infections
AU2003267936A1 (en)	2003-12-31	Methods and devices for the detection of pathogenic microorganisms and their antimicrobial susceptilbility
CA2380455A1 (en)	2001-03-01	9a-azalides with antibacterial activity
PT1227827E (pt)	2005-07-29	Bacterias acido-lacticas para o tratamento e/ou profilaxia da giardiase
NZ509051A (en)	2003-01-31	Chemotaxis-inhibiting protein of staphylococcus (CHIPS) and its use
WO2004098500A3 (en)	2005-06-02	CARBACEPHEM ss-LACTAM ANTIBIOTICS
MY104109A (en)	1993-12-31	Antibacterial 9-deoxo-9a-allyl and propargyl-9a-aza-9a-homoerythromycin a derivatives.
HK1022629A (en)	2000-08-18	Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms
EP2250887A3 (en)	2010-11-24	Use of non-antibacterial tetracycline analog CMT-1002 and formulations thereof for the treatment of bacterial exotoxins
CA2468036A1 (en)	2003-06-05	A method of treating bacterial infections using gemifloxacin or a salt thereof and a .beta.-lactam antibiotic
ES2123514T3 (es)	1999-01-16	Conjugados con receptor, destinados a dirigir farmacos y otros agentes.
AU3333695A (en)	1995-12-21	Methods and products for the control of pathogenic bacteria
AU1968399A (en)	1999-07-12	Pharmaceutical compositios containing (s)-cefuroxime axetil and their use for the treatment of bacterial infections